Mastronardi P, Santagata T, Noseda A, Mazzarella B
Istituto di Anestesia e Rianimazione e Terapia Intensiva, Università degli Studi, Napoli.
Minerva Chir. 1996 Apr;51(4):227-33.
Hypertension and tachycardia are frequently encountered in the perioperative setting. Aim of this study was to evaluate the efficacy and safety of Urapidil when used for prevention of perioperative blood pressure elevations. 348 patients, at risk for hypertensive crises, were randomly administered either Urapidil or "no treatment". Blood pressure and heart rate were measured the day before as well as immediately before intervention and were continuously monitored during the intraoperative period. This study has shown a pronounced and well tolerated antihypertensive effect of Urapidil during anaesthesia in these patients. The effect on diastolic values was specific for Urapidil, since systolic pressure was lowered also in the control group as a consequence of anaesthesia. Urapidil treatment resulted to be effective in preventing hypertensive reactions following algogenic stimulation. This becomes particularly evident towards the end of the operative period, when the hypotensive effect attributable to the anesthetic itself progressively decreases.
高血压和心动过速在围手术期较为常见。本研究的目的是评估乌拉地尔用于预防围手术期血压升高的有效性和安全性。348例有高血压危象风险的患者被随机给予乌拉地尔或“不治疗”。在干预前一天以及干预前即刻测量血压和心率,并在术中持续监测。本研究表明,乌拉地尔在这些患者麻醉期间具有显著且耐受性良好的降压作用。乌拉地尔对舒张压值的作用具有特异性,因为对照组由于麻醉收缩压也降低了。乌拉地尔治疗在预防致痛刺激后的高血压反应方面是有效的。这在手术期末尾尤为明显,此时麻醉本身所致的降压作用逐渐减弱。